Short answer · Medically reviewed summary · Last updated: 2026-05-08
Pyruvate Kinase Deficiency is a strictly hereditary, genetic condition caused by mutations in the PKLR gene. Because it follows an autosomal recessive inheritance pattern, a child must inherit two copies of the mutated gene—one from each parent—to manifest the disorder. Is Pyruvate Kinase Deficiency hereditary? Yes, Pyruvate Kinase Deficiency is an inherited metabolic disorder.
Is Pyruvate Kinase Deficiency hereditary?
Is Pyruvate Kinase Deficiency hereditary? The genetic component explained in plain language, reviewed against medical sources, with patient experiences.
Pyruvate Kinase Deficiency is a strictly hereditary, genetic condition caused by mutations in the PKLR gene. Because it follows an autosomal recessive inheritance pattern, a child must inherit two copies of the mutated gene—one from each parent—to manifest the disorder.
Is Pyruvate Kinase Deficiency hereditary?
Yes, Pyruvate Kinase Deficiency is an inherited metabolic disorder. It is not caused by lifestyle factors or environmental exposures. In medical terms, it is both genetic (caused by a change in DNA) and hereditary (passed from parents to children). Because Pyruvate Kinase Deficiency follows an autosomal recessive pattern, parents who are unaffected carriers of the gene mutation typically have a 25% chance with each pregnancy of having a child affected by the condition.
How does the inheritance of Pyruvate Kinase Deficiency work?
The PKLR gene provides instructions for making the pyruvate kinase enzyme, which is essential for red blood cell energy production. In Pyruvate Kinase Deficiency, the inheritance mechanics function as follows:
- Carrier Parents: Each parent carries one functional gene copy and one mutated copy; they usually show no symptoms.
- Inheritance Risk: For every pregnancy, there is a 25% chance of the child having Pyruvate Kinase Deficiency, a 50% chance of the child being an asymptomatic carrier, and a 25% chance of the child inheriting two functional copies.
- De Novo Mutations: Spontaneous (de novo) mutations are extremely rare in Pyruvate Kinase Deficiency; almost all cases are inherited from parents.
When is genetic testing recommended?
Genetic testing is the gold standard for confirming a diagnosis of Pyruvate Kinase Deficiency. It is highly recommended to perform molecular genetic testing of the PKLR gene to identify specific mutations. This testing is invaluable for family planning, as it allows for carrier testing of siblings and extended family members. If you are planning a pregnancy and have a family history of the condition, genetic counseling can help you understand your reproductive options, including preimplantation genetic testing (PGT) or prenatal diagnosis through amniocentesis or chorionic villus sampling (CVS).
Next steps
- Consult with a clinical geneticist to confirm your specific PKLR mutation.
- Connect with the 6 members of our Pyruvate Kinase Deficiency community at DiseaseMaps.org to share experiences.
- Request a referral to a genetic counselor to discuss family planning and carrier screening.
Medical disclaimer: This information is for educational purposes only and does not substitute professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Pyruvate kinase deficiency.
- Orphanet: Pyruvate kinase deficiency (ORPHA:776).
- OMIM (Online Mendelian Inheritance in Man): Pyruvate Kinase Deficiency of Erythrocyte (Entry #266200).
- Pyruvate Kinase Deficiency Foundation (PKDF).
